XML 213 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
End of period (in shares)       (26,704,577)        
Beginning of period (in shares) at Mar. 31, 2021     162,950,606          
Beginning of period at Mar. 31, 2021 $ 1,071,176   $ 1,629 $ (1,216,163) $ 557,957 $ 1,757,524 $ (29,771) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,224,207          
Issuance of common stock 22,170   $ 15   22,155      
Stock options exercised (in shares)     197,732          
Stock options exercised 5,929   $ 2   5,927      
Repurchase of common stock (in shares)       (5,083,620)        
Repurchase of common stock (419,291)     $ (419,291)        
Recognition of liability related to future restricted stock units vesting 1,213       1,213      
Net income 466,577         466,740   (163)
Other comprehensive income, net of tax 38,356           38,356  
Dividends paid (209,193)         (209,193)    
Stock-based compensation expense 69,784       69,784      
Contribution to non-controlling interest 0       (814)     814
End of period (in shares) at Mar. 31, 2022     164,372,545          
End of period at Mar. 31, 2022 1,046,721   $ 1,646 $ (1,635,454) 656,222 2,015,071 8,585 651
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
End of period (in shares)       (31,788,197)        
Issuance of common stock (in shares)     1,170,726          
Issuance of common stock 24,663   $ 10   24,653      
Stock options exercised (in shares)     329,061          
Stock options exercised 11,384   $ 3   11,381      
Repurchase of common stock (in shares)   (2,100,000)   (2,446,547)        
Repurchase of common stock (224,451) $ (196,200)   $ (224,451)        
Net income 271,215         271,791   (576)
Other comprehensive income, net of tax 20,748           20,748  
Dividends paid (235,407)         (235,407)    
Stock-based compensation expense 80,272       80,272      
Contribution to non-controlling interest 0       (3,068)     3,068
De-Consolidation of non-controlling interest $ (3,143)             (3,143)
End of period (in shares) at Mar. 31, 2023 131,637,588   165,872,332          
End of period at Mar. 31, 2023 $ 992,002   $ 1,659 $ (1,859,905) 769,460 2,051,455 29,333 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
End of period (in shares) 34,234,744     (34,234,744)        
Issuance of common stock (in shares)     1,194,324          
Issuance of common stock $ 28,665   $ 12   28,653      
Stock options exercised (in shares)     335,612          
Stock options exercised 15,745   $ 3   15,742      
Repurchase of common stock (in shares)   (3,200,000)   (3,524,401)        
Repurchase of common stock (417,641) $ (372,800)   $ (417,641)        
Net income 605,706         605,706   0
Other comprehensive income, net of tax (19,801)           (19,801)  
Dividends paid (253,096)         (253,096)    
Stock-based compensation expense $ 94,982       94,982      
End of period (in shares) at Mar. 31, 2024 129,643,123   167,402,268          
End of period at Mar. 31, 2024 $ 1,046,562   $ 1,674 $ (2,277,546) $ 908,837 $ 2,404,065 $ 9,532 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
End of period (in shares) 37,759,145     (37,759,145)